Oncidium foundation

The Oncidium Foundation is dedicated to promoting, supporting, and accelerating the development of radiotheranostics for cancer care worldwide. Established in 2011, the foundation aims to advance nuclear medicine therapy through the dissemination of comprehensive information for patients. It focuses on the development of radiotherapeutics and radiotheranostics, offering a new class of drugs for patients with incurable cancers. The foundation's main priorities include raising awareness among patients and physicians, investing in research and scholarships, financing the development of new radiopharmaceuticals for therapy, supporting clinical best practices, and enhancing patient access. As an organization operating in the pharmaceutical industry, Oncidium Foundation plays a crucial role in driving advancements in cancer treatment. Although specific headquarters information and recent investment details are not available at this time, the foundation's commitment to promoting innovative cancer care solutions positions it as a noteworthy entity for potential venture capital interest. The Foundation's focus on pioneering radiotheranostics and its impact on addressing unmet medical needs in cancer care make it a compelling prospect for investors looking to support groundbreaking advances in the pharmaceutical and oncology sectors.